On 11 August 2020, Russian President Vladimir Putin announced regulatory approval of the vaccine before starting phase III trials to test safety and efficacy. Mass vaccination in Russia is expected to start in October 2020, and the vaccine will be called "Sputnik V" in foreign markets.[7][8] Early approval resulted in calls to following safety guidelines from experts in Russia and abroad, as phase III has only a 40% chance of success for vaccines not sponsored by the industry.[9]